Chr
| Chronic Obstructive Pulmonary Disease | |
|---|---|
| Synonyms | N/A | 
| Pronounce | N/A | 
| Specialty | N/A | 
| Symptoms | Shortness of breath, cough, sputum production | 
| Complications | Respiratory failure, pulmonary hypertension, cor pulmonale | 
| Onset | Middle age or older | 
| Duration | Long term | 
| Types | N/A | 
| Causes | Tobacco smoking, air pollution, genetic factors | 
| Risks | Smoking, occupational exposure, indoor air pollution | 
| Diagnosis | Spirometry, chest X-ray, CT scan | 
| Differential diagnosis | N/A | 
| Prevention | N/A | 
| Treatment | Smoking cessation, bronchodilators, steroids, oxygen therapy | 
| Medication | N/A | 
| Prognosis | Variable | 
| Frequency | Common | 
| Deaths | N/A | 
Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable, and treatable disease characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases.
Epidemiology
COPD is a leading cause of morbidity and mortality worldwide. It is estimated to affect millions of people globally, with a significant number of cases remaining undiagnosed. The prevalence of COPD increases with age and is higher in men than in women, although the gender gap is closing due to increased smoking rates among women.
Pathophysiology
COPD is characterized by chronic inflammation that leads to structural changes and narrowing of the small airways. The disease encompasses two main conditions: chronic bronchitis and emphysema. Chronic bronchitis involves inflammation and narrowing of the bronchial tubes, while emphysema involves damage to the alveoli, leading to reduced surface area for gas exchange.
Chronic Bronchitis
Chronic bronchitis is defined clinically as a productive cough lasting for at least three months in two consecutive years. The inflammation in the bronchi leads to increased mucus production and airway obstruction.
Emphysema
Emphysema is characterized by the destruction of the alveolar walls and enlargement of the air spaces distal to the terminal bronchioles. This results in a loss of elastic recoil and impaired gas exchange.
Risk Factors
The primary risk factor for COPD is tobacco smoking. Other risk factors include exposure to indoor and outdoor air pollution, occupational dusts and chemicals, and genetic factors such as alpha-1 antitrypsin deficiency.
Clinical Presentation
Patients with COPD typically present with symptoms of dyspnea (shortness of breath), chronic cough, and sputum production. As the disease progresses, patients may experience weight loss, fatigue, and decreased exercise tolerance.
Diagnosis
The diagnosis of COPD is confirmed by spirometry, which demonstrates a persistent reduction in airflow. A post-bronchodilator FEV1/FVC ratio of less than 0.70 confirms the presence of airflow limitation. Additional tests such as chest X-ray and CT scan may be used to assess the extent of lung damage and rule out other conditions.
Management
Management of COPD involves both pharmacological and non-pharmacological strategies.
Pharmacological Treatment
The mainstay of pharmacological treatment includes bronchodilators such as beta-agonists and anticholinergics, and inhaled corticosteroids. Long-term oxygen therapy is indicated for patients with severe resting hypoxemia.
Non-Pharmacological Treatment
Non-pharmacological interventions include smoking cessation, pulmonary rehabilitation, and vaccination against influenza and pneumococcal infections.
Complications
Complications of COPD include frequent respiratory infections, pulmonary hypertension, and cor pulmonale. Advanced COPD can lead to respiratory failure and death.
Prognosis
The prognosis of COPD varies depending on the severity of the disease, the presence of comorbidities, and the patient's adherence to treatment. Early diagnosis and intervention can improve quality of life and reduce the risk of complications.
Prevention
Prevention of COPD primarily involves reducing exposure to risk factors, particularly smoking cessation. Public health measures to reduce air pollution and occupational exposures are also important.
See Also
External Links
- [Global Initiative for Chronic Obstructive Lung Disease (GOLD)]
 - [American Lung Association]
 
| Pulmonary diseases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
 This pulmonary disease related article is a stub. 
 | 
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
 
 - Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
 
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
 - Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
 
| 
 WikiMD's Wellness Encyclopedia  | 
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates  | 
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian 
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD